跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NAPROXEN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
NAPROXEN
Authorized
STANDARD
NAPROXEN
dominion pharmacal
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
502d4fbb1af999d3
Company
dominion pharmacal
Type
Standard
Approval Details
Approval Id
502d4fbb1af999d3
Drug Approval Canada Name
NAPROXEN
Product Name
NAPROXEN
Status
Cancelled Post Market
Status Date
2020-05-06
Original Market Date
2016-06-01
Din
02408759
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
OTC
Ahfs
28:08.04.92
Atc Original
M01AE02 NAPROXEN
Atc Name
m 01 ae 02
Aig Number
0113934003
Company Name
dominion pharmacal
Company Address
SUITE 100, 6111, Avenue Royalmount, Montreal, Quebec, Canada, H4P 2T4
Active Ingredients
NAPROXEN SODIUM
220 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
502d4fbb1af999d3
Type
Standard
Back to Health Canada Approvals